
|Articles|August 25, 2020
Inspire Announces Inspire Research Accelerator Initiative
Advertisement
Inspire Founder/CEO Brian Loew has announced a new initiative, the Inspire Research Accelerator, a program that aims to accelerate medical progress by enabling academic researchers around the world—at no cost—to collaborate with Inspire.
“The Accelerator’s goal is to enable scientific discovery by connecting researchers with patients, especially those affected by rare diseases,” Loew said.
The Accelerator will aim to help propel research in a variety of ways:
- Unlocking research gaps using longitudinal instruments, especially for personalized medicine and rare diseases
- Identifying and engaging with cancer and rare disease patient populations based on specific clinical trials experience and interest
- Rapidly deploying validated Patient-Reported Outcome (PRO) measurement tools
- Furthering exploration of complex disease underpinnings by correlating structured and unstructured data and phenotypes reported by patients with other data types such as genomics/multi-omics and other biological data
Read the full release,
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Beyond Compliance: ProofPilot's Joseph Kim and Lauren Briggs on Making Clinical Trial Training Actually Work
2
Tufts CSDD Analysis Finds AI Clinical Monitoring Agent Can Generate Up to $21 Million in Net Financial Value Per Drug Development Program
3
ACT Brief: Efficacy Ceiling Breakthrough in Autoimmune Disease, Early-Career Retention and Burnout Prevention, and PRV Program Catalyzing Rare Disease Investment
4
Breaking the Efficacy Ceiling in IBD and Beyond
5




